Factors that Motivated Otherwise Healthy HIV-Positive Young Adults to Access HIV Testing and Treatment in South Africa

被引:0
作者
R. Frederick Lambert
Catherine Orrell
David R. Bangsberg
Jessica E. Haberer
机构
[1] Harvard University,Harvard School of Dental Medicine
[2] University of Cape Town,Desmond Tutu HIV Foundation, Institute of Infectious Disease and Molecular Medicine
[3] Massachusetts General Hospital,Center for Global Health
[4] Harvard University,Harvard Medical School
来源
AIDS and Behavior | 2018年 / 22卷
关键词
Antiretroviral therapy; Human immunodeficiency virus; South Africa; Young adults; Access to care;
D O I
暂无
中图分类号
学科分类号
摘要
The World Health Organization recommends early initiation of HIV antiretroviral therapy (ART) for all those infected with the virus at any CD4 count. Successfully reaching individuals with relatively high CD4 counts depends in large part on healthy individuals seeking testing and treatment; however, little is known about factors motivating this decision. We conducted a qualitative study to explore this issue among 25 young HIV-positive adults (age 18–35) with a CD4 count >350 cells/mm3 who recently started or made the decision to start ART in Gugulethu, South Africa. Using an inductive content analytical approach, we found that most individuals sought testing and treatment early in the disease progression because of a desire to appear healthy thereby avoiding stigma associated with AIDS. Other factors included social support, responsibilities and aspirations, normalcy of having HIV, and accessible services. These findings suggest that maintenance of physical appearance should be included in the development of novel testing and treatment interventions.
引用
收藏
页码:733 / 741
页数:8
相关论文
共 147 条
  • [1] Davies E(2012)Hillary Clinton looks to an AIDS free generation Brit Med J. 345 e8203-505
  • [2] Cohen MS(2011)Prevention of HIV-1 infection with early antiretroviral therapy N Engl J Med 365 493-57
  • [3] Chen YQ(2016)How home HIV testing and counselling with follow-up support achieves high testing coverage and linkage to treatment and prevention: a qualitative analysis from Uganda J Int AIDS Soc. 19 20929-304
  • [4] McCauley M(2009)Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model Lancet 373 48-800
  • [5] Ware NC(2010)Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update Curr Opin HIV AIDS. 5 298-99
  • [6] Wyatt MA(2012)Universal access to HIV treatment versus universal ‘test and treat’: transmission, drug resistance & treatment costs PLoS ONE 7 e41212-447
  • [7] Asiimwe S(2011)The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection Clin Infect Dis 52 793-381
  • [8] Granich RM(2016)Attrition and opportunities along the HIV care continuum: findings from a population-based sample, North West Province, South Africa J Acquir Immune Defic Syndr 73 91-135
  • [9] Gilks CF(2013)Toward an understanding of disengagement from HIV treatment and care in sub-Saharan Africa: a qualitative study PLoS Med. 10 e1001369-S8
  • [10] Dye C(2003)HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa Sex Transm Infect. 79 442-273